Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Timolol (0.5% w/v) Eye Drop
Therapeutic Category
General and OTC medicines, Hypertension/ Blood Pressure, Ophthalmology, Cardiovascular
Dosage Form
Eye Drop
Packaging Type
Dropper
Packaging
5ml
Price
₹71.5/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Timshell Eye Drop contains Timolol (0.5% w/v), a beta-blocker that reduces intraocular pressure (IOP) by decreasing the production of aqueous humor in the eye. Elevated IOP is a significant risk factor for optic nerve damage and vision loss in conditions like open-angle glaucoma and ocular hypertension. By effectively lowering IOP, Timshell Eye Drop helps to protect the optic nerve and maintain vision.
Timolol is a well-established treatment in ophthalmology, offering targeted action with minimal systemic side effects. It is particularly beneficial for patients requiring long-term management of glaucoma or ocular hypertension. The eye drop is easy to administer, providing consistent and reliable results when used as prescribed by a healthcare professional.
The formulation is suitable for adult patients and is typically applied once or twice daily, as directed by a physician. It is important to adhere to the prescribed regimen to achieve optimal therapeutic outcomes.
Possible side effects include temporary eye irritation, burning sensation, or blurred vision. Rarely, systemic effects like slow heart rate or difficulty breathing may occur.
Timshell Eye Drop is indicated for the treatment of open-angle glaucoma and ocular hypertension.
Use under medical supervision. Avoid touching the dropper tip to any surface to prevent contamination. Do not use in cases of severe respiratory or heart conditions unless advised by a doctor.
Store in a cool, dry place below 25°C. Protect from light and do not freeze. Keep out of reach of children.
Composition : Timolol (5mg) + Brimonidine (2mg) Eye Drop
Composition : Sodium Carboxymethylcellulose I.P. 0.5% w/v + Oxychloro Complex 0.0075% v/v (As Perservatives) + Sterile Aqueous Base Eye Drop
Composition : Potassium Iodide (3.3% w/v) + Sodium Chloride (0.83% w/v) + Calcium Chloride (1.0% w/v)
Composition : Loteprednol etabonate (0.5% w/v)
Composition : Carboxymethylcellulose (1% w/v) + Oxychloro Complex (0.0075% w/v)
Composition : Moxifloxacin HCL I.P. 0.5% w/v + Ketorolac Tromethsmine I.P. 5% w/v Eye Drop
Composition : Dexamethasone (0.1% w/v) + Tobramycin (0.3% w/v)
Composition : Loteprednol etabonate (0.5% w/v) + Moxifloxacin (0.5% w/v)
Composition : Tobramycin (0.3% w/v) + Fluorometholone (0.1% w/v)
Composition : Timolol (0.5% w/v) Eye Drop
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Timolol 0.5% w/v Eye Drops is a beta-blocker ophthalmic formulation used for the management of glaucoma (open-angle glaucoma), ocular hypertension, and raised intraocular pressure (IOP). It works by reducing the production of aqueous humor in the eye, thereby lowering eye pressure and helping prevent optic nerve damage and vision loss. It is a valuable ophthalmology and anti-glaucoma segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent and long-term demand from ophthalmologists and eye care hospitals. Glaucoma is a chronic, progressive condition requiring lifelong therapy, ensuring: Continuous prescription cycles Strong specialist-driven demand High patient retention and repeat purchase Stable institutional and retail pharmacy sales
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities in the ophthalmic, anti-glaucoma, and eye care segments with monopoly rights, quality manufacturing standards, regulatory compliance, promotional support, and reliable supply services for distributors and medical agencies.
Wholesalers and healthcare suppliers benefit from: High chronic therapy usage Lifelong prescription-based demand Strong ophthalmology specialist market Consistent hospital and clinic consumption Stable long-term revenue potential This makes it a highly reliable and long-duration pharmaceutical franchise category.
Medical distributors, stockists, and pharma professionals interested in ophthalmic and glaucoma management formulations can contact Cafoli Lifecare to discuss product availability, pricing structure, and PCD pharma franchise opportunities in the eye care and chronic ophthalmology segment.